Director Allene M. Diaz sold 54,878 shares ($4.4M) in 3 transactions at $79.35 avg, trimming stake to 3,811 shares from 58,689.
Allene M. Diaz, a director at Ionis Pharmaceuticals, executed 3 separate sales on 2026-03-03 totaling 54,878 shares for $4,354,428.21, reducing her holding by 93.5% to just 3,811 shares. The director sold at an average price of $79.35 per share, which notably exceeds the current price of $75.16 by approximately 5.6%, though the stock has declined 11.2% over the past 30 days and 8.0% over 90 days. This large divestment is particularly significant given that Ionis is unprofitable (net income of $-128,606,000.00 in its most recent full fiscal year) despite 33.8% annual revenue growth to $156,719,000.00, highlighting the substantial gap between top-line expansion and profitability. The near-complete liquidation of a director's position warrants investor attention, especially in the context of negative earnings and recent price weakness.